FSD Pharma Announces Research Agreement with Solarvest to Develop Algae-based, Pharma-grade Cannabinoids

Process Could Significantly Reduce Cannabinoid Production Time
C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) (“FSD Pharma” or “FSD”) and Solarvest BioEnergy Inc. (TSX-V: SVS) (“Solarvest”), a technology company that developed an algal-based flexible production platform capable of producing health products, announced today that they signed a definitive collaborative research and development agreement. Under the agreement, Solarvest will conduct research using its algal expression technology to develop pharmaceutical-grade cannabinoids. FSD Pharma and Solarvest have made investments into one another and FSD has the option to enter into an exclusive license arrangement over a subset of the project and receive royalty rights over all of the products that result from the project. read more

Surface Channel Sampling at Nava Zone Returns Wide Gold Intersection 40 m at 0.7 g/t Au Including 6.0 m @1.9 g/t Au

V.GPLY, Goldplay Exploration, gold
Figure 1 Nava – Location to the west of the San Marcial Resource and the Faisanes Target (CNW Group/Goldplay Exploration Ltd)

Goldplay Exploration Ltd. (TSXV: GPLY, FRANKFURT: GPE, OTCQB: GLYXF) (“Goldplay” or the “Company”) is pleased to announce wide gold intersections in the Company’s first two surface trenches sampled to confirm the continuity and geometry of the low sulphidation epithermal gold mineralization that returned previously up to 10 g/t Au from channel sampling in underground tunnels at the Nava Zone discovery (see News Release dated 16 April 2019). read more